Inventor · disambiguated record
Paul Webb
Also filed as: WEBB PAUL · WEBB PAUL BRIAN · WEBB PAUL U
25 granted patents·11 pending applications·138 citations·filing 1976–2024
95Inventor score
Files withVERNALIS R&D LTD7UNIV CALIFORNIA6IPSEN BIOPHARM LTD3DRYSDALE MARTIN JAMES2PANJWANI NAVEED2
Top patents by PatentIndex Score
36 records- 0191US10561604B2Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucroseIPSEN BIOPHARM LTD·Filed 2017·Granted Feb 18, 2020·10 cites·9 claims
- 0289US9757329B2Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucroseIPSEN BIOPHARM LTD·Filed 2015·Granted Sep 12, 2017·8 cites·18 claims
- 0388US9125804B2Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucroseWEBB PAUL·Filed 2005·Granted Sep 8, 2015·18 cites·4 claims
- 0486US8507480B2Isoxazole compounds as inhibitors of heat shock proteinsDRYSDALE MARTIN JAMES·Filed 2010·Granted Aug 13, 2013·8 cites·30 claims
- 0584US8450310B2Isoxazole compounds as inhibitors of heat shock proteinsDRYSDALE MARTIN JAMES·Filed 2012·Granted May 28, 2013·6 cites·29 claims
- 0682US10413550B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2017·Granted Sep 17, 2019·2 cites·28 claims
- 0780US9718793B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2013·Granted Aug 1, 2017·3 cites·29 claims
- 0877US7705027B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS CAMBRIDGE LTD·Filed 2004·Granted Apr 27, 2010·7 cites·34 claims
- 0976US11234987B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2019·Granted Feb 1, 2022·0 cites·29 claims
- 1074US8551371B2Method and compositionHAWKES JAMIE ANTHONY·Filed 2008·Granted Oct 8, 2013·2 cites·11 claims
- 1171US7790680B2Stable pharmaceutical composition containing factor VIIIIPSEN PHARMA SAS·Filed 2003·Granted Sep 7, 2010·5 cites·7 claims
- 1270US4092722AFluid catalytic cracking with automatic temperature controlPHILLIPS PETROLEUM CO·Filed 1976·Granted May 30, 1978·24 cites·10 claims
- 1369US7302347B2Method for creating specific, high affinity nuclear receptor pharmaceuticalsUNIV CALIFORNIA·Filed 2002·Granted Nov 27, 2007·7 cites·24 claims
- 1468US8916591B2Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activitySTOKES STEPHEN·Filed 2009·Granted Dec 23, 2014·2 cites·17 claims
- 1567US11534394B2Pharmaceutical composition containing botulinum neurotoxinIPSEN BIOPHARM LTD·Filed 2020·Granted Dec 27, 2022·0 cites·8 claims
- 1667US6884577B2Methods for screening compounds for estrogenic activityUNIV CALIFORNIA·Filed 2000·Granted Apr 26, 2005·7 cites·20 claims
- 1764US2025228865A1Compounds for enhancing read through of genes containing premature termination codons and methods for making and using the sameSANOFI US SERVICES INC·Filed 2024·Application pending·0 cites
- 1864US2020361905A1Indolyl-Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory ActivityVERNALIS R&D LTD·Filed 2020·Application pending·0 cites
- 1961US5091570AMethod for preparation of dialkyl tellurium and dialkyl seleniumSECR DEFENCE BRIT·Filed 1988·Granted Feb 25, 1992·5 cites·34 claims
- 2059US10696652B2Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activityVERNALIS R&D LTD·Filed 2018·Granted Jun 30, 2020·0 cites·16 claims
- 2159US9604975B2Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activityVERNALIS R&D LTD·Filed 2014·Granted Mar 28, 2017·0 cites·14 claims
- 2254US2017298043A1Indolyl-Pyridone Derivatives Having Checkpoint Kinase 1 Inhibitory ActivityVERNALIS R&D LTD·Filed 2017·Application pending·0 cites
- 2353US5723291AMethods for screening compounds for estrogenic activityUNIV CALIFORNIA·Filed 1995·Granted Mar 3, 1998·19 cites·27 claims
- 2451US9890100B2Continuous process for the production of low molecular weight polyethers with a DMC catalystBAYER MATERIALSCIENCE LLC·Filed 2013·Granted Feb 13, 2018·0 cites·28 claims
- 2546US8853106B2Phosphorus-contaning flame-retardant compositionsWEBB PAUL·Filed 2007·Granted Oct 7, 2014·0 cites·7 claims
- 2643US2022289734A13,6-diamino-pyridazin-3-yl derivatives, pharmaceutical compositions containing them and their uses as pro-apoptotic agentsSERVIER LAB·Filed 2020·Application pending·0 cites
- 2743US2004253648A1Method for creating nuclear receptor activity modulating pharmaceuticalsUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 2842US2005058835A1Impregnation of polymeric substrates wit antimicrobal substances using superficial fluidsFiled 2002·Application pending·0 cites
- 2939US6117638AMethods to screen for transcription factor-coactivator interactionsUNIV CALIFORNIA·Filed 1998·Granted Sep 12, 2000·4 cites·14 claims
- 3038US2009069336A1Pyrimidothiophene compoundsBARRIL-ALONSO XAVIER·Filed 2005·Application pending·0 cites
- 3138US2008069841A1Pharmaceutical Compositions Containing Botulinum Neurotoxin A2PANJWANI NAVEED·Filed 2005·Application pending·0 cites
- 3235US6156723ACompositions comprising inhibitors of estrogen responseUNIV CALIFORNIA·Filed 1996·Granted Dec 5, 2000·1 cites·6 claims
- 3334US5117021AMethod for purification of tellurium and selenium alkylsSECR DEFENCE BRIT·Filed 1988·Granted May 26, 1992·0 cites·13 claims
- 3431US2010184689A1Pharmaceutical Composition Containing Botulinum NeurotoxinIPSEN DEVELOPMENTS LTD·Filed 2010·Application pending·0 cites
- 3530US2008102090A1Pharmaceutical Compositon Containing Botulinum Neurotoxin A2PANJWANI NAVEED·Filed 2005·Application pending·0 cites
- 3625US2002098477A1Methods for screening nuclear transcription factors for the ability to modulate an estrogen responseFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Webb files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →